2018: A Year of Achievements for NYMOX
Nymox Pharmaceutical Corporation (NYMX)
US:NASDAQ Investor Relations:
nymox.com/default.action?itemid=3
Company Research
Source: GlobeNewswire
HASBROUCK HEIGHTS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Following the Nymox (NASDAQ: NYMX) Annual General Meeting yesterday (December 18, 2018), Nymox management discussed many significant 2018 events and commented on key operational milestones coming up in 2019. Some of the more important accomplishments in 2018 included: 1) Important finding of sustained long-term benefit of Fexapotide Triflutate in early-stage prostate cancer; 2) Presentation and peer review publication of Phase III clinical trial results of pivotal Fexapotide BPH studies; 3) Pre-NDA meeting for Fexapotide in BPH; 4) Strong financial backing by long-term shareholders; 5) Manufacturing scale-up; 6) Two lines of evidence for Fexapotide benefit in prostate cancer in men: Preventative data in men being treated for BPH with Fexapotide; as well as long-term significant therapeutic data in low grade prostate cancer patients receiving Fexapotide targeted to their early stage prostate cancer; and 7) Additional extend
Show less
Read more
Impact Snapshot
Event Time:
NYMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYMX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYMX alerts
High impacting Nymox Pharmaceutical Corporation news events
Weekly update
A roundup of the hottest topics